Skip to main content
Sign In

Christina Aquilante, PharmD, FCCP

Professor, Department of Pharmaceutical Sciences

Dr. Christina Aquilante

Mailing address:

University of Colorado
Skaggs School of Pharmacy and Pharmaceutical Sciences
Mail Stop C238
12850 E. Montview Blvd. V20-4103
Aurora, CO 80045

Office Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
Fourth Floor
Room 4103

Lab Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
Fourth Floor
Room 4420A


Training and Education:

  • PharmD, University of North Carolina at Chapel Hill
  • Pharmacy Practice Residency, Shands Hospital at the University of Florida
  • Post-PharmD Research Fellowship in Cardiovascular Pharmacogenomics, University of Florida College of Pharmacy
  • Certificate in Clinical Science, University of Colorado Clinical Science Graduate Program

Research Interest:

Dr. Aquilante's patient-oriented clinical research program is aimed at identifying pharmacogenetic determinants of drug disposition, response, and adverse effects in cardiovascular and metabolic diseases. Her research has been funded by the National Institutes of Health, American Heart Association, American College of Clinical Pharmacy, American Association of Colleges of Pharmacy, pharmaceutical industry, and private foundations.

Currently, Dr. Aquilante’s clinical studies are focused on heart transplant recipients and patients with advanced heart failure. The primary goal of her work is to identify genetic predictors of drug disposition (pharmacokinetics), response (pharmacodynamics) and adverse effects in heart transplant recipients. She is also interested in identifying factors that influence medication regimen complexity and adherence in the heart transplant population. Recently, Dr. Aquilante has expanded her research program to include a cross-disciplinary and translational component. This approach is being used to elucidate mechanisms underlying left ventricular assist device (LVAD)-related adverse effects in patients with advanced heart failure.


Professional Programs:
  • PHRD 5915 Modern Drug Design and Action, Lecturer
  • PHRD 6095 Pharmacotherapy 3, Lecturer
  • PHRD 6915/7015 Seminar Research Course, Preceptor
  • PHRD 7025 Pharmacogenomics (Entry-Level PharmD Program), Course Coordinator and Lecturer
  • PHRD 7995 Clinical Capstone, Lecturer
  • P4 APPE Rotation—Clinical Research and Pharmacogenomics
  • PRDO 7780 Pharmacogenomics (North American-Trained and International-Trained PharmD Programs), Course Coordinator and Lecturer
Graduate Programs:
  • PHSC/TXCL 7310 Fundamentals of Pharmaceutical Sciences, Lecturer
  • PHSC/TXCL 7400 Ethical Issues in Toxicology and Pharmaceutical Sciences, Lecturer
  • PHSC/TXCL 7665 Pharmacokinetic Principles and Applications, Lecturer
  • CLSC 6260 Conducting Clinical Trials for Investigators, Lecturer
  • CLSC 7500 Practical Application of Molecular Biology Techniques for the Clinical Investigator, Lecturer
  • EPID 6642, Genetics in Public Health, Lecturer

Professional Awards and Service:

  • New Investigator Award, American College of Clinical Pharmacy (2008)
  • Chair, University of Colorado School of Pharmacy Admissions Committee (2010-2014)
  • Fellow, American College of Clinical Pharmacy (2015)
  • Vice Chair, Task Force on Collaborative Research Opportunities, American College of Clinical Pharmacy (2015-2016)
  • Member, Inter-Society Coordinating Committee for Practitioner Education in Genetics and Genomics (ISCC), National Human Genome Research Institute (NHGRI/NIH)
  • Chair, Research Affairs Committee, American College of Clinical Pharmacy (2016-2017)
  • Chair, Pharmacogenomics Special Interest Group (SIG), American Association of Colleges of Pharmacy (2017-2018)
  • Co-Chair, Pharmacogenomics Implementation Committee Colorado (2016-present)

Continuing Education:

  • Pharmacogenomics Certificate Program: Dr. Aquilante developed and teaches an online, practice-based, clinical pharmacogenomics certificate program for pharmacists, physicians and nurses. For more information click here.
  • International Clinical Pharmacogenomics Training Symposium: Dr. Aquilante developed and teaches a live, practice-based, clinical pharmacogeomics education symposium for pharmacists, physicians, and nurses. This program has been delivered at Children's Cancer Hospital Egypt (57357) in Cairo, Egypt.

Representative Publications:

  • Aquilante CL, Niemi M, Gong L, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8. Pharmacogenet Genomics. 2013; 23(12):721-8.
  • Aquilante CL, Page RL, Vu A, Roscoe N, Wolfel EE, Lindenfeld JA. Comparison of Office, Home, and Ambulatory Blood Pressure in Heart Transplant Recipients. J Card Fail. 2014; 20(8):602-10.
  • Bryant BM, Libby AM, Metz KR, Page RL II, Ambardekar AV, Lindenfeld J, Aquilante CL. Evaluating patient-level medication regimen complexity over time in heart transplant recipients. Ann Pharmacother. 2016; 50(11): 926-934.
  • Weitzel KW, Aquilante CL, Johnson S, Kisor DF, Empey PE. Educational strategies to enable expansion of pharmacogenomics-based care. Am J Health Syst Pharm. 2016; 73(23): 1986-1998.
  • Deininger KM, Vu A, Page II, Ambardekar AV, Lindenfeld J, Aquilante CL. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients. Clin Transplant. 2016; 30(9):1074-8.
  • Cobretti MR, Page RL 2nd, Linnebur SA, Deininger KM, Ambardekar AV, Lindenfeld J, Aquilante CL. Medication regimen complexity in ambulatory older adults with heart failure. Clin Interv Aging. 2017: 12:679-686.
  • Jurgens PT, Aquilante CL, Page RL 2nd, Ambardekar AV. Perioperative Management of Cardiac Transplant Recipients Undergoing Noncardiac Surgery: Unique Challenges Created by Advancements in Care. Semin Cardiothorac Vasc Anesth. 2017 May 1 [Epub ahead of print] PMID: 28466755.